Jin Medical International Statistics Share Statistics Jin Medical International has 156.55M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 156.55M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 0.64% Shares Floating 37.82M Failed to Deliver (FTD) Shares 6,541 FTD / Avg. Volume 2.93%
Short Selling Information The latest short interest is 752.53K, so 0.48% of the outstanding
shares have been sold short.
Short Interest 752.53K Short % of Shares Out 0.48% Short % of Float 1.52% Short Ratio (days to cover) 3.28
Valuation Ratios The PE ratio is 114.51 and the forward
PE ratio is null.
Jin Medical International's PEG ratio is
6.13.
PE Ratio 114.51 Forward PE n/a PS Ratio 17.91 Forward PS n/a PB Ratio 14.61 P/FCF Ratio -180.53 PEG Ratio 6.13
Financial Ratio History Enterprise Valuation Jin Medical International has an Enterprise Value (EV) of 424.39M.
EV / Sales 18.06 EV / EBITDA 106.5 EV / EBIT -351.52 EV / FCF -182.02
Financial Position The company has a current ratio of 2.5,
with a Debt / Equity ratio of 0.4.
Current Ratio 2.5 Quick Ratio 2.08 Debt / Equity 0.4 Debt / EBITDA 2.91 Debt / FCF -4.98 Interest Coverage 0
Financial Efficiency Return on Equity is 12.76% and Return on Invested Capital is 7.41%.
Return on Equity 12.76% Return on Assets 8.03% Return on Invested Capital 7.41% Revenue Per Employee $87.37K Profits Per Employee $13.67K Employee Count 269 Asset Turnover 0.51 Inventory Turnover 1.97
Taxes Income Tax 763.88K Effective Tax Rate 18.26%
Stock Price Statistics The stock price has increased by -79.5% in the
last 52 weeks. The beta is 9.86, so Jin Medical International's
price volatility has been higher than the market average.
Beta 9.86 52-Week Price Change -79.5% 50-Day Moving Average 0.67 200-Day Moving Average 0.9 Relative Strength Index (RSI) 52 Average Volume (20 Days) 223,611
Income Statement In the last 12 months, Jin Medical International had revenue of 23.5M
and earned 3.68M
in profits. Earnings per share was 0.02.
Revenue 23.5M Gross Profit 9.5M Operating Income 3.64M Net Income 3.68M EBITDA 3.98M EBIT 3.64M Earnings Per Share (EPS) 0.02
Full Income Statement Balance Sheet The company has 8.14M in cash and 11.6M in
debt, giving a net cash position of -3.47M.
Cash & Cash Equivalents 8.14M Total Debt 11.6M Net Cash -3.47M Retained Earnings 20.02M Total Assets 45.8M Working Capital 25.66M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1.21M
and capital expenditures -1.12M, giving a free cash flow of -2.33M.
Operating Cash Flow -1.21M Capital Expenditures -1.12M Free Cash Flow -2.33M FCF Per Share -0.01
Full Cash Flow Statement Margins Gross margin is 40.43%, with operating and profit margins of 15.48% and 15.64%.
Gross Margin 40.43% Operating Margin 15.48% Pretax Margin 17.8% Profit Margin 15.64% EBITDA Margin 16.96% EBIT Margin 15.48% FCF Margin -9.92%
Dividends & Yields ZJYL does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 0.87% FCF Yield -0.55%
Dividend Details Analyst Forecast Currently there are no analyst rating for ZJYL.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $0.59 Lynch Upside -9.23% Graham Number 0.31 Graham Upside -52.31%
Stock Splits The last stock split was on Feb 8, 2024. It was a
forward
split with a ratio of 20:1.
Last Split Date Feb 8, 2024 Split Type forward Split Ratio 20:1
Scores Altman Z-Score 5.64 Piotroski F-Score 3
